These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10661388)

  • 41. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.
    Nelson KM; Schram BR; McGregor MW; Sheoran AS; Olsen CW; Lunn DP
    Vaccine; 1998 Aug; 16(13):1306-13. PubMed ID: 9682395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
    Fougerolle S; Legrand L; Garrett D; Birand I; Foursin M; D'Ablon X; Bayssat P; Newton RJ; Pronost S; Paillot R
    Vaccine; 2016 Jul; 34(33):3787-95. PubMed ID: 27269055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Equine influenza: a review of an unpredictable virus.
    Daly JM; MacRae S; Newton JR; Wattrang E; Elton DM
    Vet J; 2011 Jul; 189(1):7-14. PubMed ID: 20685140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013.
    Kim EJ; Kim BH; Yang S; Choi EJ; Shin YJ; Song JY; Shin YK
    J Vet Med Sci; 2015 Nov; 77(11):1517-21. PubMed ID: 26062436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outbreak of equine influenza among horses in Hong Kong during 1992.
    Powell DG; Watkins KL; Li PH; Shortridge KF
    Vet Rec; 1995 May; 136(21):531-6. PubMed ID: 7660556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012).
    Gildea S; Fitzpatrick DA; Cullinane A
    Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):61-72. PubMed ID: 24224821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom.
    Edlund Toulemonde C; Daly J; Sindle T; Guigal PM; Audonnet JC; Minke JM
    Vet Rec; 2005 Mar; 156(12):367-71. PubMed ID: 15816180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine failure caused an outbreak of equine influenza in Croatia.
    Barbic L; Madic J; Turk N; Daly J
    Vet Microbiol; 2009 Jan; 133(1-2):164-71. PubMed ID: 18632226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine.
    Kannegieter NJ; Frogley A; Crispe E; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():139-42. PubMed ID: 21711313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza.
    El-Hage CM; Savage CJ; Minke JM; Ficorilli NP; Watson J; Gilkerson JR
    Equine Vet J; 2013 Mar; 45(2):235-9. PubMed ID: 22943193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.
    Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ
    Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
    Paillot R; Prowse L
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proof of freedom from equine influenza infection in Australia in 2007-08.
    Scott-Orr H
    Aust Vet J; 2011 Jul; 89 Suppl 1():163-4. PubMed ID: 21711321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination program in the response to the 2007 equine influenza outbreak in Australia.
    Perkins NR; Webster WR; Wright T; Denney I; Links I
    Aust Vet J; 2011 Jul; 89 Suppl 1():126-34. PubMed ID: 21711310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza.
    Tabynov K; Kydyrbayev Zh; Ryskeldinova Sh; Assanzhanova N; Sansyzbay A
    Vaccine; 2014 May; 32(25):2965-71. PubMed ID: 24726250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current perspectives on control of equine influenza.
    Daly JM; Newton JR; Mumford JA
    Vet Res; 2004; 35(4):411-23. PubMed ID: 15236674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan.
    Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Matsumura T; Kokado H; Gildea S; Cullinane A
    J Vet Med Sci; 2018 Mar; 80(2):382-386. PubMed ID: 29237998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant.
    Mumford JA; Wilson H; Hannant D; Jessett DM
    Epidemiol Infect; 1994 Apr; 112(2):421-37. PubMed ID: 8150017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Equine Influenza Virus and Vaccines.
    Oladunni FS; Oseni SO; Martinez-Sobrido L; Chambers TM
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.